logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

LR/mBCa: dual HER2-blockade plus taxane does well in PERUSE

Findings consistent with CLEOPATRA and support paclitaxel as an alternative to docetaxel.